MS patients denied licensed cannabis drug by NHS
MS patients denied licensed cannabis drug by NHS
The NHS has been criticised by doctors for denying multiple sclerosis patients access to a drug derived from cannabis which regulators have approved to help relieve their symptoms.
MS specialists claim primary care trusts (PCTs) in England are exacerbating patients' pain and suffering by refusing to let them use Sativex. Some PCTs say the drug, which costs £11 a day, is not worth the money, but doctors insist it is the only medication that can help some patients.
Sativex can relieve spasticity, or muscle stiffness, in MS patients. It became the first cannabis-based medicine to be licensed for use in the UK almost a year ago by the Medicines and Healthcare products Regulatory Agency (MHRA). ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1540 Views
-
Last post by frodo
-
- 0 Replies
- 1540 Views
-
Last post by NHE
-
- 0 Replies
- 1670 Views
-
Last post by NHE
-
- 0 Replies
- 521 Views
-
Last post by NHE
-
- 1 Replies
- 3160 Views
-
Last post by Tif
-
- 0 Replies
- 2451 Views
-
Last post by frodo
-
- 0 Replies
- 97 Views
-
Last post by DIM
-
- 5 Replies
- 14364 Views
-
Last post by gibbledygook
-
- 2 Replies
- 1082 Views
-
Last post by DIM